The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Tenax Therapeutics Inc shares valued at $25,542 were purchased by Rich Stuart on Dec 09 ’25. At $10.22 per share, Rich Stuart acquired 2,500 shares. The insider’s holdings grew to 5,266 shares worth approximately $96209.81999999999 following the completion of this transaction.
Also, Rich Stuart purchased 2,500 shares, netting a total of over 25,250 in proceeds. Following the buying of shares at $10.10 each, the insider now holds 5,000 shares.
Before that, Rich Stuart had added 2,500 shares to its account. In a trade valued at $22,998, the Chief Medical Officer bought Tenax Therapeutics Inc shares for $9.20 each. Upon closing the transaction, the insider’s holdings increased to 2,500 shares, worth approximately $45675.0.
As published in their initiating research note from Piper Sandler on September 08, 2025, Tenax Therapeutics Inc [TENX] has been an Overweight and the price target has been revised to $20. Analysts at Leerink Partners started covering the stock with ‘”an Outperform”‘ outlook in a report released in late October. As of October 14, 2024, Guggenheim has initiated its “Buy” rating for TENX. Earlier on September 30, 2024, William Blair initiated its rating. Their recommendation was “an Outperform” for TENX stock.
Analyzing TENX Stock Performance
On last trading session, Tenax Therapeutics Inc [NASDAQ: TENX] rose 21.40% to $18.27. The stock’s lowest price that day was $14.8, but it reached a high of $18.38 in the same session. During the last five days, there has been a surge of approximately 42.18%. Over the course of the year, Tenax Therapeutics Inc shares have jumped approximately 196.59%.
Is Tenax Therapeutics Inc subject to short interest?
Stocks of Tenax Therapeutics Inc saw a sharp steep in short interest on 2025-12-31 dropping by -0.51 million shares to 93087.0. Data from Yahoo Finance shows that the short interest on 2025-11-28 was 0.6 million shares. A decline of -545.06% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 0.46 of the overall float, the days-to-cover ratio (short ratio) decline to 0.46.
Which companies own the most shares of Tenax Therapeutics Inc (TENX)?
In terms of Tenax Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 22.5 in the next 12 months, up nearly 49.5% from the previous closing price of $15.05. Analysts anticipate Tenax Therapeutics Inc stock to reach 25 by 2026, with the lowest price target being 20.
